DARA BioSciences, Inc. (DARA) Starts Presentation at 2015 Marcum MicroCap Conference

DARA BioSciences is an oncology supportive care pharmaceutical company dedicated to providing health care professionals a portfolio of medicines to help cancer patients stick to their therapy and manage side effects arising from their cancer treatment. DARA holds exclusive U.S. marketing rights to the Soltamox(tamoxifen citrate) oral solution, Gelclair oral rinse gel, and Oravig(miconazole). For more information, visit the company’s website at www.darabiosciences.com